On-Demand Webinar
The effectiveness of inhalation devices relies on their ability to deliver the pharmaceutical directly to the targeted part of the body with precision and calculated dosing. Since these devices are used by patients instead of trained healthcare providers, user error is common and can impact the patient’s wellbeing. In addition, since the devices are typically placed in open cavities such as the nose or mouth, contamination of the device from viral or bacterial particles found in those cavities can decrease the safety of the device.
In this webinar designed for inhalation device engineers, learn how to use porous polymer technology to create a single custom component that can solve these multiple design challenges and bring your new inhalation device to market. Regardless of system design, porous polymers can be used to direct flow with precision, meter dosing, and filter out viruses and bacteria. With the increasing trend towards delivering drugs to the central nervous system via the nasal cavity, engineers will learn how porous polymers can be used to enable precise and calculated dosing in this specific type of design.
In this webinar, you will:
- Understand the science behind filtration, wicking, and diffusion that can be used to solve common inhalation device challenges.
- Learn how to enable precise and calculated dosing when delivering drugs directly to the central nervous system (CNS) via the nasal cavity.
- See examples of inhalation design challenges that were solved with porous polymers.
- Learn how the collaborative innovation process works when designing custom porous polymer materials.
* This webinar is not available to Porex competitors.
Host Biography:
Nadia Hajjar
Category Manager – Life Sciences, Porex
Nadia is the Category Manager for Life Sciences solutions at Porex. Nadia has 10 years of international healthcare experience in the areas of Manufacturing, R&D, Operations, Product Development, Marketing, and Business Development. An expert in our sintered and fiber technologies, Nadia leads a global team to develop a robust product portfolio focused on drug delivery for applications such as injectables, inhalation, and topical application. Nadia holds an MBA from the University of Edinburgh Business School.